Top Markets
#1 Siren Siren +33.52%
#2 Wiki Cat Wiki Cat +25.95%
#3 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +17.28%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.59%
#7 Cysic Cysic +15.77%
#8 Bitway Bitway +15.75%
#9 The Grays Currency The Grays Currency +15.71%
#10 Wrapped Pulse Wrapped Pulse +15.37%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rank in Stocks #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Share Price
$0.089
Last synced: 2026-08-17
Market Cap
$15.36M
Change (1 day)
50.59%
Change (1 year)
111.85%
Country
US
Trade Inhibitor Therapeutics, Inc. (INTI)

Category

Healthcare
Operating Margin for Inhibitor Therapeutics, Inc. (INTI)
Operating Margin as of 2026 TTM: 0.00%
According to Inhibitor Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Inhibitor Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.